Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals

Core Insights - MIG Capital disclosed a reduction in its holdings of Sotera Health, selling 2,262,292 shares valued at approximately $37.41 million [1][2] - The total position value for Sotera Health declined by $31.83 million at the end of the fourth quarter of 2025, reflecting both trading and share price changes [2] Company Overview - Sotera Health is a leading provider of sterilization and laboratory services, supporting critical supply chains in healthcare, pharmaceuticals, and food safety [5] - The company operates a service-based business model generating revenue through sterilization, laboratory testing, and consulting for regulated industries [8] - As of the latest data, Sotera Health's market capitalization is $3.8 billion, with a revenue of $1.16 billion and a net income of $77.95 million for the trailing twelve months [4] Financial Performance - In 2025, Sotera Health achieved a 5.7% increase in sales to $1.16 billion, while adjusted EBITDA rose by 8.2% to approximately $594 million [6] - The net income nearly doubled from the previous year to $78 million, indicating significant progress on the bottom line [6] - The company expects revenue growth between 5% and 6.5% in 2026, with adjusted EBITDA projected to grow between 5.5% and 7% [10] Market Position - Despite the reduction in holdings, Sotera Health still represents nearly 6% of MIG Capital's portfolio assets, indicating continued confidence in the company [7] - Sotera Health shares were priced at $13.41, reflecting an 18% increase over the past year, slightly underperforming the S&P 500's approximately 20% gain [7] - The company serves a diverse range of clients, including medical device manufacturers, pharmaceutical companies, and food/agricultural producers across North America and Europe [8]